FDA Coronavirus (COVID-19) Update: June 16th, 2020
June 16, 2020
Silver Spring, MD – The U.S. Food and Drug Administration is continuing to take action in the ongoing response to the COVID-19 Coronavirus pandemic:
Today, FDA revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate donated to the Strategic National Stockpile to be used to treat certain hospitalized patients with COVID-19 Coronavirus when a clinical trial was unavailable, or participation in a clinical trial was not feasible.
Coronavirus
